Andreasen, NC (1984
a). The Scale for the Assessment of Negative Symptoms (SANS). University of Iowa: Iowa City, IA.
Andreasen, NC (1984
b). The Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa: Iowa City, IA.
Awad, AG (2012). Is it time to consider comorbid substance abuse as a new indication for antipsychotic drug development?
Journal of Psychopharmacology
Berg, SA, Chambers, RA (2008). Accentuated behavioral sensitization to nicotine in the neonatal ventral hippocampal lesion model of schizophrenia. Neuropharmacology
Berg, SA, Sentir, AM, Cooley, BS, Engleman, EA, Chambers, RA (2013). Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesions. Addiction Biology. Published online:
. doi: 10.1111/adb.12082.
Chambers, RA, Krystal, JH, Self, DW (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry
Chatterton, R, Sanderson, L, Van Leent, S, Plant, K (1998). Does clozapine affect smoking rates?
Australian and New Zealand Journal of Psychiatry
Copersino, ML, Serper, MR, Vadhan, N, Goldberg, BR, Richarme, D, Chou, JC, Stitzer, M, Cancro, R (2004). Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients. Psychiatry Research
Dawe, S, Gerda, C, Russell, MA, Gray, J (1995). Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology
de Leon, J, Diaz, FJ (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research
de Leon, J, Diaz, FJ, Josiassen, RC, Cooper, TB, Simpson, GM (2005). Does clozapine decrease smoking?
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Field, M, Cox, WM (2008). Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug and Alcohol Dependence
Field, M, Munafò, MR, Franken, IHA (2009). A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse. Psychological Bulletin
Fonder, MA, Sacco, KA, Termine, A, Boland, BS, Seyal, AA, Dudas, MM, Vessicchio, JC, George, TP (2005). Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist. Biological Psychiatry
Franken, IHA (2003). Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Progress in Neuro-Psychopharmacology and Biological Psychiatry
Franken, IHA, Hendriks, VM, Stam, CJ, Van den Brink, W (2004). A role for dopamine in the processing of drug cues in heroin dependent patients. European Neuropsychopharmacology
Freeman, TP, Morgan, CJA, Pepper, F, Howes, OD, Stone, JM, Curran, HV (2012). Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug use. Psychopharmacology
George, TP, Sernyak, MJ, Ziedonis, DM, Woods, SW (1995). Effects of clozapine on smoking in chronic schizophrenic outpatients. Journal of Clinical Psychiatry
Gray, J, Feldon, J, Rawlins, J, Hemsley, D, Smith, A (1991). The neuropsychology of schizophrenia. Behavioral and Brain Sciences
Green, A, Drake, R, Brunette, M, Noordsy, D (2007). Schizophrenia and co-occurring substance use disorder. American Journal of Psychiatry
Hahn, B, Harvey, AN, Concheiro-Guisan, M, Huestis, MA, Holcomb, HH, Gold, JM (2013). A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biological Psychiatry
Heatherton, TF, Kozlowski, LT, Frecker, RC, Fagerström, KO (1991). The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction
Heinz, A, Schlagenhauf, F (2010). Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophrenia Bulletin
Hennekens, CH, Hennekens, AR, Hollar, D, Casey, DE (2005). Schizophrenia and increased risks of cardiovascular disease. American Heart Journal
Irving, C, Adams, C, Lawrie, S (2006). Haloperidol versus placebo for schizophrenia. Cochrane Database of Systematic Reviews. Issue 4, Art. No. CD003082.
Janes, AC, Pizzagalli, DA, Richardt, S (2010). Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biological Psychiatry
Jensen, J, Willeit, M, Zipursky, RB, Savina, I, Smith, AJ, Menon, M, Crawley, AP, Kapur, S (2007). The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology
Jentsch, JD, Taylor, JR (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology
Jones, SH, Gray, JA, Hemsley, DR (1992). Loss of the Kamin blocking effect in acute but not chronic schizophrenics. Biological Psychiatry
Kapur, S (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry
Kelly, DL, McMahon, RP, Wehring, HJ, Liu, F, Mackowick, KM, Boggs, DL, Warren, KR, Feldman, S, Shim, JC, Love, RC, Dixon, L (2011). Cigarette smoking and mortality risk in people with schizophrenia. Schizophrenia Bulletin
Kotov, R, Guey, LT, Bromet, EJ, Schwartz, JE (2010). Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity. Schizophrenia Bulletin
Kotz, D, Brown, J, West, R (2012). Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking. Drug and Alcohol Dependence
Krishnadas, R, Jauhar, S, Telfer, S, Shivashankar, S, McCreadie, RG (2012). Nicotine dependence and illness severity in schizophrenia. British Journal of Psychiatry
Kumari, V, Postma, P (2005). Nicotine use in schizophrenia: the self medication hypotheses. Neuroscience and Biobehavioral Reviews
Leweke, FM, Piomelli, D, Pahlisch, F, Muhl, D, Gerth, CW, Hoyer, C, Klosterkötter, J, Hellmich, M, Koethe, D (2012). Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational Psychiatry
Luijten, M, Veltman, DJ, den Brink, W, Hester, R, Field, M, Smits, M, Franken, IHA (2011). Neurobiological substrate of smoking-related attentional bias. NeuroImage
Luijten, M, Veltman, DJ, Hester, R, Smits, M, Pepplinkhuizen, L, Franken, IHA (2012). Brain activation associated with attentional bias in smokers is modulated by a dopamine antagonist. Neuropsychopharmacology
Mason, O, Linney, Y, Claridge, G (2005). Short scales for measuring schizotypy. Schizophrenia Research
McEvoy, JP, Freudenreich, O, Levin, ED, Rose, JE (1995
a). Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology
McEvoy, JP, Freudenreich, O, McGee, M, VanderZwaag, C, Levin, ED, Rose, JE (1995
b). Clozapine decreases smoking in patients with chronic schizophrenia. Biological Psychiatry
Morgan, CJA, Das, RK, Joye, A, Curran, HV, Kamboj, SK (2013). Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings. Addictive Behaviors
Morgan, CJA, Freeman, TP, Schafer, GL, Curran, HV (2010). Cannabidiol attenuates the appetitive effects of Δ9-tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology
Murray, G, Corlett, P, Clark, L, Pessiglione, M, Blackwell, AD, Honey, G, Jones, PB, Bullmore, ET, Robbins, TW, Fletcher, PC (2007). Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Molecular Psychiatry
Nelson, HE (1991). National Adult Reading Test (NART). NFER-Nelson: Windsor, UK.
Powell, J, Dawkins, L, West, R, Powell, J, Pickering, A (2010). Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology
Robinson, TE, Berridge, KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research Reviews
Roiser, JP, Howes, OD, Chaddock, CA, Joyce, EM, McGuire, P (2012). Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis. Schizophrenia Bulletin. Published online:
. doi: 10.1093/schbul/sbs147
Roiser, JP, Stephan, KE, den Ouden, HE, Barnes, TR, Friston, KJ, Joyce, EM (2009). Do patients with schizophrenia exhibit aberrant salience?
Romaniuk, L, Honey, GD, King, JR, Whalley, HC, McIntosh, AM, Levita, L, Hughes, M, Johnstone, EC, Day, M, Lawrie, SM, Hall, J (2010). Midbrain activation during Pavlovian conditioning and delusional symptoms in schizophrenia. Archives of General Psychiatry
Tidey, JW, Rohsenow, DJ, Kaplan, GB, Swift, RM, Adolfo, AB (2008). Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls. Nicotine and Tobacco Research
Tsapakis, EM, Guillin, O, Murray, RM (2003). Does dopamine sensitization underlie the association between schizophrenia and drug abuse?
Current Opinion in Psychiatry
Tseng, KY, Chambers, RA, Lipska, BK (2009). The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia. Behavioural Brain Research
van Os, J (2009). ‘Salience syndrome’ replaces ‘schizophrenia’ in DSM-V and ICD-11: psychiatry's evidence-based entry into the 21st century?
Acta Psychiatrica Scandinavica
Vollstädt-Klein, S, Loeber, S, Winter, S, Leménager, T, von der Goltz, C, Dinter, C, Koopmann, A, Wied, C, Winterer, G, Kiefer, F (2011). Attention shift towards smoking cues relates to severity of dependence, smoking behavior and breath carbon monoxide. European Addiction Research
Waters, AJ, Shiffman, S, Sayette, MA, Paty, JA, Gwaltney, CJ, Balabanis, MH (2003). Attentional bias predicts outcome in smoking cessation. Health Psychology
WHO (1993). The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. World Health Organization: Geneva.
Wing, VC, Wass, CE, Soh, DW, George, TP (2012). A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Annals of the New York Academy of Sciences